Extended-term cannabis end users are at risk for establishing cannabinoid hyperemesis syndrome (CHS), characterised by recurrent bouts of intensive vomiting and abdominal cramping for the duration of or in 48 hours of weighty cannabis use.[108] The mechanism driving CHS is badly recognized which is contrary into the antiemetic Attributes of cannabi